IIT Madras researchers and NASA's Jet Propulsion Laboratory (JPL) are currently studying multi-drug resistant pathogens found on the ISS. Their study focuses on the Enterobacter bugandensis bacterial species isolated from the ISS.
This bacterial strain is believed to have evolved, becoming more potent within the closed environment of the space station.
NASA has been studying this bacteria for a while, and in April, reported "Thirteen strains of E. bugandensis, a bacterium notorious for being multi-drug resistant, were isolated from the ISS."
As per the study, due to stress, the strains isolated in the ISS had mutated, becoming "genetically and functionally distinct compared to their Earth counterparts."
As per NASA, these strains could persist in the ISS over time, and has co-existed with other microorganisms, even possibly helping other organisms survive in some cases.
"Our comprehensive analysis illuminated not only the ways these interactions sculpt microbial diversity but also the factors that might contribute to the potential dominance and succession of E bugandensis within the ISS environment," the study published in Microbiome says.
There are two-fold implications of these findings. Firstly, they help understand microbial behaviour, how they adapt, and how evolution works in extreme, isolated environments. Secondly, these findings 'underscore the need for robust preventive measures, ensuring the health and safety of astronauts by mitigating risks associated with potential pathogenic threats.'
NASA noted that closed human-built environments like the ISS are unique areas which provide extreme environments subject to microgravity, elevated carbon dioxide levels, and radiation. Microorganisms introduced to these areas must adapt in order to survive, NASA added. "By delving into microbial dynamics in extreme environments, this research opens doors to effective preventative measures for astronaut health," the space agency has said.